Cantor Fitzgerald, L. P. »

Intellia Therapeutics shares owned by Cantor Fitzgerald, L. P.

Quarter-by-quarter ownership of Intellia Therapeutics (NTLA) shares owned by Cantor Fitzgerald, L. P. from 13F filings

Historical chart of Cantor Fitzgerald, L. P. investment in Intellia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Intellia Therapeutics held by Cantor Fitzgerald, L. P. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intellia Therapeutics by Cantor Fitzgerald, L. P.

Quarter filed Position value Share count Share price at filing
2025-03-31 $71k 10k 7.11

More positions owned by Cantor Fitzgerald, L. P.

Strategy Cl A (MSTR)
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Advanced Micro Devices (AMD)
Tesla Motors (TSLA)
Robinhood Mkts Com Cl A (HOOD)
Super Micro Computer Inc Com Usd0.001 (SMCI)
UnitedHealth (UNH)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Rocket Lab Corp (RKLB)
Fidelity Wise Origin Bitcoin SHS (FBTC)
Oracle Corporation (ORCL)
Oklo Com Cl A (OKLO)
Broadcom (AVGO)
Rigetti Computing Common Stock (RGTI)

View all positions for Cantor Fitzgerald, L. P.

Top funds holding Intellia Therapeutics

ARK Investment Management
Vanguard Group
BlackRock
Contrarius Group Holdings
State Street Corporation
Goldman Sachs Group
Morgan Stanley
Regeneron Pharmaceuticals
Baker Bros. Advisors
Geode Capital Management
Two Sigma Investments
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
D. E. Shaw & Co
Two Sigma Advisers

View all funds holding Intellia Therapeutics